Compare EAT & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EAT | BIO |
|---|---|---|
| Founded | 1975 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.2B |
| IPO Year | 1994 | N/A |
| Metric | EAT | BIO |
|---|---|---|
| Price | $139.95 | $269.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 4 |
| Target Price | $184.41 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 1.1M | 304.0K |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 144.71 | N/A |
| EPS | ★ 5.03 | N/A |
| Revenue | ★ $5,384,200,000.00 | N/A |
| Revenue This Year | $8.99 | $2.51 |
| Revenue Next Year | $5.47 | $3.17 |
| P/E Ratio | $26.64 | ★ $9.72 |
| Revenue Growth | ★ 21.95 | N/A |
| 52 Week Low | $100.30 | $211.43 |
| 52 Week High | $187.12 | $343.12 |
| Indicator | EAT | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 41.07 | 37.86 |
| Support Level | $137.33 | $266.71 |
| Resistance Level | $154.19 | $290.01 |
| Average True Range (ATR) | 6.39 | 7.21 |
| MACD | -1.14 | 0.67 |
| Stochastic Oscillator | 33.84 | 13.13 |
Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.